We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

RLYB Rallybio Holdings LLC

0.02 (1.38%)
19 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Rallybio Holdings LLC RLYB NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.02 1.38% 1.47 14:00:06
Open Price Low Price High Price Close Price Previous Close
1.45 1.395 1.475 1.40 1.45
more quote information »

Recent News

Date Time Source Heading
17/6/202422:00BWRallybio Announces Results of Epidemiological Analysis..
22/5/202406:22EDGAR2Form 8-K - Current report
21/5/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
18/5/202407:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202407:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/5/202406:02EDGAR2Form S-3 - Registration statement under Securities Act of..
10/5/202406:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:11EDGAR2Form 8-K - Current report
09/5/202422:00BWRallybio Reports First Quarter 2024 Financial Results and..
07/5/202422:00BWRallybio to Present at the 2024 Citizens JMP Life Sciences..
18/4/202406:01BWFNAIT Systematic Literature Review and Meta-Analysis..
11/4/202406:01BWRallybio Announces Collaboration to Advance Therapeutic..
02/4/202401:05BWRallybio Announces FNAIT Systematic Literature Review to be..
12/3/202423:00BWRallybio Reports Fourth Quarter and Full Year 2023 Financial..
27/2/202400:00BWRallybio to Present at the TD Cowen 44th Annual Health Care..
17/2/202410:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202400:15EDGAR2Form 8-K - Current report
07/2/202400:00BWRallybio Announces Portfolio Prioritization and Provides..
05/1/202400:00BWRallybio Highlights Portfolio Advances and Outlines Expected..
21/12/202300:15EDGAR2Form 8-K - Current report
21/12/202300:00BWRallybio Announces Preliminary Phase 1 Multiple Ascending..
10/12/202304:00BWRallybio Presents Natural History Study for Fetal and..
28/11/202323:00BWRallybio Announces Preliminary Multiple Dose Data from the..
10/11/202308:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202300:10EDGAR2Form 8-K - Current report
10/11/202300:00BWRallybio Reports Third Quarter 2023 Financial Results and..
09/11/202300:00BWRallybio to Present at Upcoming Investor Conferences in..
03/11/202300:15BWRallybio Announces Acceptance of FNAIT Natural History Study..
03/10/202323:00BWRallybio to Present at the JonesTrading 2023 Healthcare..
04/9/202302:00BWRallybio Presents Phase 1 Single Ascending Dose Data for..
31/8/202322:00BWRallybio to Present at Upcoming Investor Conferences in..
09/8/202306:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:16EDGAR2Form 8-K - Current report
08/8/202322:00BWRallybio Reports Second Quarter 2023 Financial Results and..
02/8/202322:00BWRallybio to Present at the 2023 Wedbush PacGrow Healthcare..
11/7/202322:00BWRallybio Announces Acceptance of Abstract for RLYB116 at the..
29/6/202321:30EDGAR2Form 8-K - Current report
29/6/202321:00BWRallybio Announces Succession Plan; Appoints Stephen Uden,..
25/6/202305:30BW Rallybio Announces Proof-of-Concept Results and Development..

Your Recent History

Delayed Upgrade Clock